CPT® Code 0423T

Deleted

1. Indications

The secretory type II phospholipase A2 (sPLA2-IIA) test is indicated for the following conditions:

• Coronary Artery Disease (CAD) - Elevated levels of sPLA2-IIA are often found in patients with CAD, making this test useful for assessing cardiovascular risk.
• Atherosclerosis - The test may be utilized to evaluate the presence and severity of atherosclerosis, as increased sPLA2-IIA levels can indicate inflammatory processes associated with this condition.
• Risk Assessment Prior to Cardiovascular Events - This test can aid in predicting an individual's risk for CAD before a cardiovascular event occurs, providing valuable information for preventive measures.
• Recurrent Cardiac Events - In patients who have presented with acute myocardial infarction or unstable angina, the test may help predict the likelihood of subsequent cardiac events or sudden cardiac death.

2. Procedure

The procedure for measuring secretory type II phospholipase A2 (sPLA2-IIA) involves several key steps:

• Step 1: Patient Preparation - Prior to the test, the patient may be instructed to follow specific guidelines regarding fasting or medication adjustments, although these details are not explicitly provided in the CPT® data.
• Step 2: Blood Sample Collection - A blood sample is obtained through a venipuncture, which is a standard procedure where a needle is inserted into a vein to draw blood. This step is crucial as the plasma obtained will be used for the analysis of sPLA2-IIA levels.
• Step 3: Plasma Preparation - Once the blood sample is collected, it is processed to separate the plasma from the cellular components. This is typically done through centrifugation, which allows for the isolation of the plasma needed for testing.
• Step 4: Testing Methodology - The plasma sample is then analyzed using the enzyme-linked immunosorbent assay (ELISA) technique. This method involves the use of specific antibodies that bind to sPLA2-IIA, allowing for the quantification of its levels in the plasma.

3. Post-Procedure

After the procedure, the patient may experience minimal discomfort at the venipuncture site, which typically resolves quickly. There are no specific post-procedure care instructions provided in the CPT® data. However, it is generally advisable for patients to hydrate adequately and monitor the site for any unusual symptoms, such as excessive bleeding or signs of infection. The results of the sPLA2-IIA test will be interpreted in conjunction with clinical evaluations and other diagnostic tools to provide a comprehensive assessment of the patient's cardiovascular risk.